ZR Pharma

ZR Pharma & GmbH is an Austrian pharmaceutical company headquartered in Vienna that specializes in the marketing and distribution of dermatological products. The company's portfolio is centered on established topical treatments for skin conditions, most notably Solaraze (diclofenac sodium) and Zyclara (imiquimod), which are used to treat actinic keratosis. In 2020, ZR Pharma was acquired by Dermapharm Holding SE, a leading German manufacturer of off-patent specialty pharmaceuticals. Today, the company operates as a subsidiary within the Dermapharm group, contributing to its presence in the European dermatology market. Its business model focuses on the acquisition and optimization of high-value brands in the specialty healthcare sector.